Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric D

Go back to Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric D
(NASDAQ: WGRX) Delayed: 3.39 -0.31 (8.38%)
Previous Close $3.70    52 Week High
Open $3.65    52 Week Low
Day High $3.65    P/E N/A 
Day Low $3.39    EPS
Volume 34,006